Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice (Q51463179)

5 April 2018

title

Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice (English)

1 reference

5 April 2018

0 references

1 reference

1 reference

1 reference

5 April 2018

author name string

Alli M Nuotio-Antar

series ordinal

1 reference

5 April 2018

David L Hachey

series ordinal

1 reference

5 April 2018

publication date

18 September 2007

1 reference

5 April 2018

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

5 April 2018

volume

293

1 reference

5 April 2018

issue

1 reference

5 April 2018

page(s)

E1517-28

1 reference

5 April 2018

Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

11beta-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Does central obesity reflect "Cushing's disease of the omentum"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

TNF-alpha plus IFN-gamma induce connexin43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Role of melanocortinergic neurons in feeding and the agouti obesity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Carbenoxolone does not cross the blood brain barrier: an HPLC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

The forms and functions of 11 beta-hydroxysteroid dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Communication via gap junctions modulates bile secretion in the isolated perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Identification of a biochemical link between energy intake and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Quantitative assessment of atherosclerotic lesions in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Hypercortisolism and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Dexamethasone regulates bile acid synthesis in monolayer cultures of rat hepatocytes by induction of cholesterol 7 alpha-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Hypertension and the cortisol-cortisone shuttle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Tissue-specific dysregulation of cortisol metabolism in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Transforming growth factor beta secretion from primary breast cancer fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Determination of corticosteroids in tissue samples by liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Gap-junctional communication is required for mitotic clonal expansion during adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00522.2007

10.1152/AJPENDO.00522.2007

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018